Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2014

Open Access 01-12-2014 | Research

Utility of the waist-to-height ratio, waist circumference and body mass index in the screening of metabolic syndrome in adult patients with type 1 diabetes mellitus

Authors: Aldo Ferreira-Hermosillo, Claudia Ramírez-Rentería, Victoria Mendoza-Zubieta, Mario A Molina-Ayala

Published in: Diabetology & Metabolic Syndrome | Issue 1/2014

Login to get access

Abstract

Background

The incidence of macrovascular complications and morbidities associated to metabolic syndrome are increasing in patients with type 1 diabetes mellitus (T1DM). The combination of T1DM with features of insulin resistance similar to that of type 2 diabetes (T2DM), sometimes called “double diabetes”, has been associated with central obesity. Since the most methods to accurately detect body fat and insulin resistance are not readily available, we propose that certain indirect indexes for detecting obesity as waist-to-height ratio, waist circumference and body mass index, may be useful when screening for metabolic syndrome in patients with T1DM.

Methods

We performed a transversal evaluation (clinical and biochemical) in all the patients of the T1DM Clinic (n = 120). We determined the presence of metabolic syndrome according to the Joint Statement Criteria by the American Heart Association/ National Heart Lung and Blood Institute and the International Diabetes Federation and the utility of certain anthropometric indexes for predicting double diabetes was evaluated.

Results

Thirty seven percent of the patients were considered to have metabolic syndrome using these criteria (n = 30). These patients were significantly older (p = 0.002), have a higher glycated hemoglobin (p = 0.036), cholesterol (p < 0.012) and triglyceride concentration (p < 0.01) as well as body mass index (p = 0.004), waist circumference (p = 0.01) and waist-to-height ratio (p < 0.01) than the group without metabolic syndrome. Also their c-HDL is lower (p < 0.01). A value of 0.52 for waist-to-height ratio correctly classified the largest number of patients (68% of correctly classified) well as the waist circumference (66% of correctly classified) with an adequate specificity and sensibility. Meanwhile the most precise body mass index value only classified correctly to 61% of patients.

Conclusion

Our data show that waist circumference and waist-to-height ratio indexes are useful to predict the presence of metabolic syndrome in adult patients with type 1 diabetes mellitus.
Appendix
Available only for authorised users
Literature
2.
go back to reference Gomez-Diaz RA, Perez-Perez G, Hernandez-Cuesta IT, Rodriguez-Garcia Jdel C, Guerrero-Lopez R, Aguilar-Salinas CA, Wacher NH: Incidence of type 1 diabetes in Mexico: data from an institutional register 2000–2010. Diabetes Care. 2012, 35 (11): e77-10.2337/dc12-0844.PubMedCentralCrossRefPubMed Gomez-Diaz RA, Perez-Perez G, Hernandez-Cuesta IT, Rodriguez-Garcia Jdel C, Guerrero-Lopez R, Aguilar-Salinas CA, Wacher NH: Incidence of type 1 diabetes in Mexico: data from an institutional register 2000–2010. Diabetes Care. 2012, 35 (11): e77-10.2337/dc12-0844.PubMedCentralCrossRefPubMed
3.
go back to reference Chillaron JJ, Flores-Le-Roux JA, Goday A, Benaiges D, Carrera MJ, Puig J, Cano-Perez JF, Pedro-Botet J: Metabolic syndrome and type-1 diabetes mellitus: prevalence and associated factors. Rev Esp Cardiol. 2010, 63 (4): 423-429. 10.1016/S0300-8932(10)70063-4.CrossRefPubMed Chillaron JJ, Flores-Le-Roux JA, Goday A, Benaiges D, Carrera MJ, Puig J, Cano-Perez JF, Pedro-Botet J: Metabolic syndrome and type-1 diabetes mellitus: prevalence and associated factors. Rev Esp Cardiol. 2010, 63 (4): 423-429. 10.1016/S0300-8932(10)70063-4.CrossRefPubMed
4.
go back to reference Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988, 37 (12): 1595-1607. 10.2337/diab.37.12.1595.CrossRefPubMed Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988, 37 (12): 1595-1607. 10.2337/diab.37.12.1595.CrossRefPubMed
5.
go back to reference Barrera-Cruz A, Avila-Jimenez L, Cano-Perez E, Molina-Ayala MA, Parrilla-Ortiz JI, Ramos-Hernandez RI, Sosa-Caballero A, Sosa-Ruiz Mdel R, Gutierrez-Aguilar J: Practice clinical guideline. Prevention, diagnosis and treatment of overweight and obesity. Rev Med Inst Mex Seguro Soc. 2013, 51 (3): 344-357.PubMed Barrera-Cruz A, Avila-Jimenez L, Cano-Perez E, Molina-Ayala MA, Parrilla-Ortiz JI, Ramos-Hernandez RI, Sosa-Caballero A, Sosa-Ruiz Mdel R, Gutierrez-Aguilar J: Practice clinical guideline. Prevention, diagnosis and treatment of overweight and obesity. Rev Med Inst Mex Seguro Soc. 2013, 51 (3): 344-357.PubMed
6.
go back to reference Teupe B, Bergis K: Epidemiological evidence for “double diabetes”. Lancet. 1991, 337 (8737): 361-362.CrossRefPubMed Teupe B, Bergis K: Epidemiological evidence for “double diabetes”. Lancet. 1991, 337 (8737): 361-362.CrossRefPubMed
7.
go back to reference Waki H, Tontonoz P: Endocrine functions of adipose tissue. Annu Rev Pathol. 2007, 2: 31-56. 10.1146/annurev.pathol.2.010506.091859.CrossRefPubMed Waki H, Tontonoz P: Endocrine functions of adipose tissue. Annu Rev Pathol. 2007, 2: 31-56. 10.1146/annurev.pathol.2.010506.091859.CrossRefPubMed
8.
go back to reference Shuster A, Patlas M, Pinthus JH, Mourtzakis M: The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012, 85 (1009): 1-10. 10.1259/bjr/38447238.PubMedCentralCrossRefPubMed Shuster A, Patlas M, Pinthus JH, Mourtzakis M: The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012, 85 (1009): 1-10. 10.1259/bjr/38447238.PubMedCentralCrossRefPubMed
9.
go back to reference Schneider HJ, Glaesmer H, Klotsche J, Bohler S, Lehnert H, Zeiher AM, Marz W, Pittrow D, Stalla GK, Wittchen HU: Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab. 2007, 92 (2): 589-594. 10.1210/jc.2006-0254.CrossRefPubMed Schneider HJ, Glaesmer H, Klotsche J, Bohler S, Lehnert H, Zeiher AM, Marz W, Pittrow D, Stalla GK, Wittchen HU: Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab. 2007, 92 (2): 589-594. 10.1210/jc.2006-0254.CrossRefPubMed
10.
go back to reference Ashwell M, Gibson S: Waist to height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: analysis of data from the British National Diet And Nutrition Survey of adults aged 19–64 years. Obes Facts. 2009, 2 (2): 97-103. 10.1159/000203363.CrossRefPubMed Ashwell M, Gibson S: Waist to height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: analysis of data from the British National Diet And Nutrition Survey of adults aged 19–64 years. Obes Facts. 2009, 2 (2): 97-103. 10.1159/000203363.CrossRefPubMed
11.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
12.
go back to reference Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18 (6): 499-502.PubMed Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18 (6): 499-502.PubMed
13.
go back to reference Akobeng AK: Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007, 96 (5): 644-647. 10.1111/j.1651-2227.2006.00178.x.CrossRefPubMed Akobeng AK: Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007, 96 (5): 644-647. 10.1111/j.1651-2227.2006.00178.x.CrossRefPubMed
14.
go back to reference Cleland SJ: Cardiovascular risk in double diabetes mellitus-when two worlds collide. Nat Rev Endocrinol. 2012, 8 (8): 476-85. 10.1038/nrendo.2012.47.CrossRefPubMed Cleland SJ: Cardiovascular risk in double diabetes mellitus-when two worlds collide. Nat Rev Endocrinol. 2012, 8 (8): 476-85. 10.1038/nrendo.2012.47.CrossRefPubMed
15.
go back to reference Berber A, Gomez-Santos R, Fanghanel G, Sanchez-Reyes L: Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population. Int J Obes Relat Metab Disord. 2001, 25 (12): 1794-1799. 10.1038/sj.ijo.0801827.CrossRefPubMed Berber A, Gomez-Santos R, Fanghanel G, Sanchez-Reyes L: Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population. Int J Obes Relat Metab Disord. 2001, 25 (12): 1794-1799. 10.1038/sj.ijo.0801827.CrossRefPubMed
16.
go back to reference Ferreira Hermosillo A, Vargas Ortega G, Gonzalez Virla B, Mercado Atri M, Molina Ayala M: Prevalence of metabolic syndrome (MS) in patients with type 1 diabetes (DM1). Gac Med Mex. 2012, 148 (2): 137-143.PubMed Ferreira Hermosillo A, Vargas Ortega G, Gonzalez Virla B, Mercado Atri M, Molina Ayala M: Prevalence of metabolic syndrome (MS) in patients with type 1 diabetes (DM1). Gac Med Mex. 2012, 148 (2): 137-143.PubMed
17.
go back to reference Thorn LM, Forsblom C, Waden J, Saraheimo M, Tolonen N, Hietala K, Groop PH: Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2009, 32 (5): 950-952. 10.2337/dc08-2022.PubMedCentralCrossRefPubMed Thorn LM, Forsblom C, Waden J, Saraheimo M, Tolonen N, Hietala K, Groop PH: Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2009, 32 (5): 950-952. 10.2337/dc08-2022.PubMedCentralCrossRefPubMed
18.
go back to reference Radikova Z: Assessment of insulin sensitivity/resistance in epidemiological studies. Endocr Regul. 2003, 37 (3): 189-194.PubMed Radikova Z: Assessment of insulin sensitivity/resistance in epidemiological studies. Endocr Regul. 2003, 37 (3): 189-194.PubMed
19.
go back to reference Cleland SJ, Fisher BM, Colhoun HM, Sattar N, Petrie JR: Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?. Diabetologia. 2013, 56 (7): 1462-1470. 10.1007/s00125-013-2904-2.PubMedCentralCrossRefPubMed Cleland SJ, Fisher BM, Colhoun HM, Sattar N, Petrie JR: Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?. Diabetologia. 2013, 56 (7): 1462-1470. 10.1007/s00125-013-2904-2.PubMedCentralCrossRefPubMed
20.
go back to reference Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ: Can clinical factors estimate insulin resistance in type 1 diabetes?. Diabetes. 2000, 49 (4): 626-632. 10.2337/diabetes.49.4.626.CrossRefPubMed Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ: Can clinical factors estimate insulin resistance in type 1 diabetes?. Diabetes. 2000, 49 (4): 626-632. 10.2337/diabetes.49.4.626.CrossRefPubMed
21.
go back to reference Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ: The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes. 2006, 55 (5): 1463-1469. 10.2337/db05-1423.CrossRefPubMed Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ: The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes. 2006, 55 (5): 1463-1469. 10.2337/db05-1423.CrossRefPubMed
22.
go back to reference Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, Orchard TJ: Temporal patterns in overweight and obesity in type 1 diabetes. Diabet Med. 2010, 27 (4): 398-404. 10.1111/j.1464-5491.2010.02956.x.PubMedCentralCrossRefPubMed Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, Orchard TJ: Temporal patterns in overweight and obesity in type 1 diabetes. Diabet Med. 2010, 27 (4): 398-404. 10.1111/j.1464-5491.2010.02956.x.PubMedCentralCrossRefPubMed
23.
go back to reference Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD: Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA. 1998, 280 (2): 140-146. 10.1001/jama.280.2.140.PubMedCentralCrossRefPubMed Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD: Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA. 1998, 280 (2): 140-146. 10.1001/jama.280.2.140.PubMedCentralCrossRefPubMed
24.
go back to reference Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD: Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes. 2000, 49 (3): 485-491. 10.2337/diabetes.49.3.485.CrossRefPubMed Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD: Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes. 2000, 49 (3): 485-491. 10.2337/diabetes.49.3.485.CrossRefPubMed
25.
go back to reference Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD: von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999, 19 (12): 3071-3078. 10.1161/01.ATV.19.12.3071.CrossRefPubMed Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD: von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999, 19 (12): 3071-3078. 10.1161/01.ATV.19.12.3071.CrossRefPubMed
26.
go back to reference Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB: Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005, 54 (2): 534-539. 10.2337/diabetes.54.2.534.CrossRefPubMed Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB: Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005, 54 (2): 534-539. 10.2337/diabetes.54.2.534.CrossRefPubMed
27.
go back to reference Rodrigues TC, Canani LH, Gross JL: Metabolic syndrome, insulin resistance and cardiovascular disease in type-1 diabetes mellitus]. Arq Bras Cardiol. 2010, 94 (1): 134-139. 10.1590/S0066-782X2010000100020.CrossRefPubMed Rodrigues TC, Canani LH, Gross JL: Metabolic syndrome, insulin resistance and cardiovascular disease in type-1 diabetes mellitus]. Arq Bras Cardiol. 2010, 94 (1): 134-139. 10.1590/S0066-782X2010000100020.CrossRefPubMed
29.
go back to reference Ness-Abramof R, Apovian CM: Waist circumference measurement in clinical practice. Nutr Clin Pract. 2008, 23 (4): 397-404. 10.1177/0884533608321700.CrossRefPubMed Ness-Abramof R, Apovian CM: Waist circumference measurement in clinical practice. Nutr Clin Pract. 2008, 23 (4): 397-404. 10.1177/0884533608321700.CrossRefPubMed
30.
go back to reference Hsieh SD, Yoshinaga H: Do people with similar waist circumference share similar health risks irrespective of height?. Tohoku J Exp Med. 1999, 188 (1): 55-60. 10.1620/tjem.188.55.CrossRefPubMed Hsieh SD, Yoshinaga H: Do people with similar waist circumference share similar health risks irrespective of height?. Tohoku J Exp Med. 1999, 188 (1): 55-60. 10.1620/tjem.188.55.CrossRefPubMed
31.
go back to reference Liu Y, Tong G, Tong W, Lu L, Qin X: Can body mass index, waist circumference, waist-hip ratio and waist-height ratio predict the presence of multiple metabolic risk factors in Chinese subjects?. BMC Public Health. 2011, 11: 35-10.1186/1471-2458-11-35.PubMedCentralCrossRefPubMed Liu Y, Tong G, Tong W, Lu L, Qin X: Can body mass index, waist circumference, waist-hip ratio and waist-height ratio predict the presence of multiple metabolic risk factors in Chinese subjects?. BMC Public Health. 2011, 11: 35-10.1186/1471-2458-11-35.PubMedCentralCrossRefPubMed
32.
go back to reference Han TS, Williams K, Sattar N, Hunt KJ, Lean ME, Haffner SM: Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res. 2002, 10 (9): 923-931. 10.1038/oby.2002.126.CrossRefPubMed Han TS, Williams K, Sattar N, Hunt KJ, Lean ME, Haffner SM: Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res. 2002, 10 (9): 923-931. 10.1038/oby.2002.126.CrossRefPubMed
33.
go back to reference Schneider HJ, Klotsche J, Stalla GK, Wittchen HU: Obesity and risk of myocardial infarction: the INTERHEART study. Lancet. 2006, 367 (9516): 1052-10.1016/S0140-6736(06)68462-6. author reply 1054CrossRefPubMed Schneider HJ, Klotsche J, Stalla GK, Wittchen HU: Obesity and risk of myocardial infarction: the INTERHEART study. Lancet. 2006, 367 (9516): 1052-10.1016/S0140-6736(06)68462-6. author reply 1054CrossRefPubMed
34.
go back to reference Bener A, Yousafzai MT, Darwish S, Al-Hamaq AO, Nasralla EA, Abdul-Ghani M: Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio. J Obes. 2013, 2013: 269038-PubMedCentralCrossRefPubMed Bener A, Yousafzai MT, Darwish S, Al-Hamaq AO, Nasralla EA, Abdul-Ghani M: Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio. J Obes. 2013, 2013: 269038-PubMedCentralCrossRefPubMed
35.
go back to reference Ashwell M, Gunn P, Gibson S: Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012, 13 (3): 275-286. 10.1111/j.1467-789X.2011.00952.x.CrossRefPubMed Ashwell M, Gunn P, Gibson S: Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012, 13 (3): 275-286. 10.1111/j.1467-789X.2011.00952.x.CrossRefPubMed
36.
go back to reference Elizondo-Montemayor L, Serrano-Gonzalez M, Ugalde-Casas PA, Bustamante-Careaga H, Cuello-Garcia C: Waist-to-height: cutoff matters in predicting metabolic syndrome in Mexican children. Metab Syndr Relat Disord. 2011, 9 (3): 183-190. 10.1089/met.2010.0116.CrossRefPubMed Elizondo-Montemayor L, Serrano-Gonzalez M, Ugalde-Casas PA, Bustamante-Careaga H, Cuello-Garcia C: Waist-to-height: cutoff matters in predicting metabolic syndrome in Mexican children. Metab Syndr Relat Disord. 2011, 9 (3): 183-190. 10.1089/met.2010.0116.CrossRefPubMed
Metadata
Title
Utility of the waist-to-height ratio, waist circumference and body mass index in the screening of metabolic syndrome in adult patients with type 1 diabetes mellitus
Authors
Aldo Ferreira-Hermosillo
Claudia Ramírez-Rentería
Victoria Mendoza-Zubieta
Mario A Molina-Ayala
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2014
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-6-32

Other articles of this Issue 1/2014

Diabetology & Metabolic Syndrome 1/2014 Go to the issue